Sanofi Diet Drug Impressive in 2-Year Study
602
An experimental diet drug helped  people lose nearly four times as much weight as a placebo in an  eagerly anticipated two-year trial, researchers said on  Tuesday.
405152
People who adopt four healthy principles can add as much as 14 years to their lives, study reveals
409429
A new drug from Sanofi-Aventis reduced significantly episodes of atrial fibrillaton or irregular heart beat in two clinical studies released on Sunday.
659831
A European study offers more evidence that weekly injections of interferon beta reduce the risk that people with early symptoms of multiple sclerosis will progress to the full-blown disease within two years.
144292
After about two decades of trying to develop a vaccine against malaria, GlaxoSmithKline Biologicals has achieved a breakthrough of sorts.
333366
The Food and Drug Administration approved a drug for multiple sclerosis that works by a new mode of action and has shown early evidence of being more effective than existing drugs.
252691
Two shots of the cancer drug Rituxan given two weeks apart slowed the progression of multiple sclerosis for nearly a year, researchers reported on Wednesday.
475056
Expectations rose for Sanofi-Aventis's big new drug hope Acomplia on Friday as the French firm revealed it would present two-year, rather than one-year, data on the anti-obesity medicine next week.
599854
LONDON (CBS.MW) -- Newly merged French pharmaceutical Sanofi-Aventis (SNY) (FR:012057) on Tuesday said it can confirm the accretive impact of the merger on 2004 proforma net income after Sanofi-Synthelabo posted a 20.
594161
Genzyme announces positive study results with a recently acquired drug.
562572
Sanofi-Aventis SA's anti-thrombotic   drug Lovenox reduces the risk of death or new heart attacks in   patients undergoing artery clearance more effectively than an   older -- but still widely used -- medicine.
589264
Panacos releases more clinical trial results for an exciting drug.
581198
A drug used to treat diabetes also seems to prevent it in people at high risk of developing the disease, the largest study ever to test this has found.
64529
French pharmaceuticals group Sanofi-Aventis said on Wednesday that data showed improvements in work performance in patients with chronic insomnia treated with its blockbuster Ambien drug .
458557
An experimental drug from  Sanofi-Aventis, viewed as pivotal to the newly merged company's  future, showed good results in the largest clinical study of  the product to date.
239723
A new Sanofi-Aventis meningitis vaccine aimed at protecting adolescents throughout their college years is safe and effective but should undergo longer-term studies
762042
A new Sanofi-Aventis  meningitis vaccine aimed at protecting adolescents throughout their college years is safe and effective but should undergo longer-term studies if approved, a panel of U.S. experts concluded on Wednesday.